Bacteria-targeted magnetic resonance contrast agents

Lauren M. Matosziuk; Allison S. Harney; Keith William Macrenaris; Thomas J Meade

Bacteria-targeted magnetic resonance contrast agents

Lauren M. Matosziuk (Inventor), Allison S. Harney (Inventor), Keith William Macrenaris (Inventor), Thomas J Meade (Inventor)

Research output: Patent

Abstract

The present invention relates to bacteria-targeted contrast agents for magnetic resonance imaging (MRI). In particular, the present invention relates to bacteria targeted MRI contrast agents that can be used to detect bacteria in vivo or in vitro. In certain embodiments, the contrast agents comprise a metal chelate conjugated to at least two Zn-dipicolylamine groups.

Original language	English (US)
Patent number	9566355
Filing date	3/6/14
State	Published - Feb 14 2017

Fingerprint Dive into the research topics of 'Bacteria-targeted magnetic resonance contrast agents'. Together they form a unique fingerprint.

Cite this

@misc{abca1c15798f4c5983e0f1541300a949,

title = "Bacteria-targeted magnetic resonance contrast agents",

abstract = "The present invention relates to bacteria-targeted contrast agents for magnetic resonance imaging (MRI). In particular, the present invention relates to bacteria targeted MRI contrast agents that can be used to detect bacteria in vivo or in vitro. In certain embodiments, the contrast agents comprise a metal chelate conjugated to at least two Zn-dipicolylamine groups.",

author = "Matosziuk, {Lauren M.} and Harney, {Allison S.} and Macrenaris, {Keith William} and Meade, {Thomas J}",

note = "Filed: March 6, 2014; 9566355",

year = "2017",

month = feb,

day = "14",

language = "English (US)",

type = "Patent",

}

TY - PAT

T1 - Bacteria-targeted magnetic resonance contrast agents

AU - Matosziuk, Lauren M.

AU - Harney, Allison S.

AU - Macrenaris, Keith William

AU - Meade, Thomas J

N1 - Filed: March 6, 2014

PY - 2017/2/14

Y1 - 2017/2/14

N2 - The present invention relates to bacteria-targeted contrast agents for magnetic resonance imaging (MRI). In particular, the present invention relates to bacteria targeted MRI contrast agents that can be used to detect bacteria in vivo or in vitro. In certain embodiments, the contrast agents comprise a metal chelate conjugated to at least two Zn-dipicolylamine groups.

AB - The present invention relates to bacteria-targeted contrast agents for magnetic resonance imaging (MRI). In particular, the present invention relates to bacteria targeted MRI contrast agents that can be used to detect bacteria in vivo or in vitro. In certain embodiments, the contrast agents comprise a metal chelate conjugated to at least two Zn-dipicolylamine groups.

M3 - Patent

M1 - 9566355

Y2 - 2014/03/06

ER -